NCT02193074 A Study to Assess the Efficacy and Safety of Nusinersen (ISIS 396443) in Infants With Spinal Muscular Atrophy Status TERMINATED Phase PHASE3
NCT02176031 Phase II Trial of Natalizumab + Prednisone for Initial Therapy of Acute GI GVHD Status COMPLETED Phase PHASE2
NCT02171208 A Healthy Volunteer Study to Establish the Bioequivalence of BG00012 Supplied by 2 Different Commercial Manufacturers Status COMPLETED Phase PHASE1
NCT02159573 Real-world Outcomes on Tecfidera (BG00012, Dimethyl Fumarate) Post-Tysabri (BG00002, Natalizumab) Status COMPLETED Phase N/A
NCT02143167 Resistance Training and Amino Pyridine in Multiple Sclerosis Status COMPLETED Phase PHASE4
NCT02142959 RTA 408 Lotion in Patients at Risk for Radiation Dermatitis - PRIMROSE Status COMPLETED Phase PHASE2
NCT02142205 Safety and Efficacy of Natalizumab (BG00002, Tysabri®) in Russian Participants With Relapsing Remitting Multiple Sclerosis (RRMS) Status COMPLETED Phase PHASE4
NCT02137109 Safety and Efficacy in Pediatric MS Patients Prescribed Tysabri Status COMPLETED Phase N/A
NCT02133924 Multicenter Study Of Natalizumab Plus Standard Steroid Treatment For High Risk Acute Graft-Versus-Host Disease Status COMPLETED Phase PHASE2
NCT02128113 RTA 408 Ophthalmic Suspension for the Prevention of Corneal Endothelial Cell Loss Following Cataract Surgery - GUARD Status COMPLETED Phase PHASE2
NCT02125604 Gastrointestinal Tolerability Study Of Dimethyl Fumarate In Participants With Relapsing-Remitting Multiple Sclerosis In Germany Status COMPLETED Phase PHASE4
NCT02125578 A Multiple Dose Safety Study of PEG-IFN in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT02106897 Study Evaluating the Safety, Tolerability, and Pharmacokinetics of Single Doses and Multiple Doses of BIIB059 (Litifilimab) in Healthy Volunteers and Participants With Systemic Lupus Erythematosus Status COMPLETED Phase PHASE1
NCT02099370 Adherence to Treatment With Tecfidera™ in Multiple Sclerosis Patients Status COMPLETED Phase N/A
NCT02097849 Vaccination Response in Tecfidera-Treated Versus Interferon-Treated Participants With Relapsing Forms of Multiple Sclerosis. Status COMPLETED Phase PHASE2
NCT02097745 A Study of the Efficacy and Safety of Re-treatments With Rituximab in Patients With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Anti-tnfa Therapies Status COMPLETED Phase PHASE3
NCT02090413 Phase 4 Study of Effect of Aspirin on Flushing in Dimethyl Fumarate-Treated Participants With Relapsing-Remitting Multiple Sclerosis Status COMPLETED Phase PHASE4
NCT02090348 Study to Evaluate Fatigue in Participants With Relapsing Remitting Multiple Sclerosis When Treated With Dimethyl Fumarate Status WITHDRAWN Phase PHASE4